# US 2016/0304916 A1 · Pichia ciferrii cells and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0304916 A1
- Document ID: US20160304916A1
- Status: Published application
- Kind: A1
- Application number: 15/193,513
- Filed: 2016-06-27
- Published: 2016-10-20
- Earliest claimed: 2011-08-18
- Assignees: Evonik Degussa GmbH
- Applicants: Evonik Degussa GmbH
- Inventors: Tim Köhler; Christoph Schorsch; Eckhard Boles; Heiko Andrea; Mike Farwick; Steffen Schaffer
- Web page: https://patentgrep.com/patent/US20160304916A1

## CPC

- C12P 13/02: Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}
- C07K 14/39: from yeasts
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/0073: {with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13}
- C12N 9/1014: {Hydroxymethyl-, formyl-transferases (2.1.2)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C12N 9/88: Lyases (4.)
- C12N 15/815: {for yeasts other than Saccharomyces}
- C12Y 114/13169: Sphinganine C4-monooxygenase (1.14.13.169)
- C12Y 203/0105: Serine C-palmitoyltransferase (2.3.1.50)
- C12Y 207/01091: Sphinganine kinase (2.7.1.91)
- C12Y 401/02027: Sphinganine-1-phosphate aldolase (4.1.2.27)
- Y02P 20/52: using catalysts, e.g. selective catalysts
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.

## Claims

### Claim 1

A genetically modified Pichia ciferrii cell, wherein said genetically modified Pichia ciferrii cell has, compared to its wild type, a reduced activity of at least one of the enzymes encoded by the intron-free nucleic acid sequences selected from the two groups A) and B) consisting of:
A) SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11; and
B) a sequence which is at least 80% identical to any of the sequences SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11.

### Claim 2 (depends on 1)

The genetically modified Pichia ciferrii cell according to claim 1, characterized in that wherein said reduction of the enzymic enzymatic activity is achieved by modifying a gene comprising any of the nucleic acid sequences specified in claim 1, wherein the modification is selected from the group consisting of:
insertion of foreign DNA into the gene,
deletion of at least a portion of the gene,
point mutations in the gene sequence,
exposing the gene to the influence of RNA interference, and
replacement of a portion of the gene with foreign DNA.

### Claim 3 (depends on 2)

The genetically modified Pichia ciferrii cell according to claim 2, wherein said foreign DNA is a selection marker gene that can be removed without leaving a trace and which leaves a deletion in the target gene.

### Claim 4 (depends on 1)

The genetically modified Pichia ciferrii cell according to claim 1, wherein the Pichia ciferrii cell is obtained from strains selected from the group consisting of
Pichia ciferrii NRRL Y-1031 F-60-10; and
Pichia ciferrii CS.PCAPro2.

### Claim 5 (depends on 1)

The genetically modified Pichia ciferrii cell according to claim 1, characterized in that the cell further has, compared to its wild type, an increased enzymatic activity of at least one of the enzymes selected from the group consisting of;
enzyme E1, wherein enzyme E1 catalyses the reaction of serine and palmitoyl-CoA to give 3-ketosphinganine, in particular a serine palmitoyl transferase, in particular those encoded by Seq ID No 13 and/or Seq ID No 15; and
enzyme E2, wherein enzyme E2 catalyses the reaction of sphinganine to phytosphingosine, in particular a sphinganine C4-hydroxylase, in particular that encoded by Seq ID No 17.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

Method of producing a genetically modified Pichia ciferri cell of claim 1, said method comprising:
I) providing a Pichia ciferrii cell, and
II) modifying at least one gene comprising any of the sequences set forth in groups A) and B) specified in claim 1 by:
insertion of foreign DNA, wherein said insertion is DNA coding for a selection marker gene;
deletion of at least a portion of the gene;
insertion of a point mutation in the gene sequence;
exposing the gene to the influence of RNA interference; or
replacement of a portion of the gene with foreign DNA.

### Claim 8 (depends on 1)

A Method of producing sphingoid bases and sphingolipids, said method comprising the steps of
a) contacting a genetically modified cell according to claim 1 with a medium including a carbon source,
b) culturing the cell from step a) under conditions which enable the cell to produce sphingoid bases and sphingolipids from said carbon source, and
c) optionally isolating the sphingoid bases and sphingolipids produced.
